NCT02207465 2025-11-19A Phase I Dual Dose Escalation Study of Radiation and Nab-Paclitaxel in Patients With Unresectable and Borderline Resectable Pancreatic CancerAbramson Cancer Center at Penn MedicinePhase 1 Active not recruiting42 enrolled